An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, Feb. 24, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
Political and business leaders are rethinking AI—as not just a technology to regulate but as a force to accelerate. Medicine ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesKey biosimilar value driver contributes to Sandoz global growth strategy ...
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...
Lupin and its alliance partner Natco received clearance from the FDA for bosentan tablets for oral suspension, 32 mg, which ...
As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...
Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).
Just because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...
AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...